Inspire Medical Systems price to free cash flow INSP
Market value divided by free cash flow over the last twelve months, since 2023.
- Today, Nov 2, 2026
- 16.6×
- 3-year median
- 30.3×
- Against its 3-year history
- 15th
- percentile: 0 is its lowest day, 100 its highest
- 3-year range
- 11.9× to 458×
- Peer median
- 26.4×
Inspire Medical Systems' price to free cash flow is 16.6× as of Nov 2, 2026.
That is below its 3-year median of 30.3×, lower than on 85% of days in the last 3 years.
Over that time it ranged from 11.9× in May 2026 to 458× in Nov 2023.
The median for 10 medical instruments and supplies stocks of a similar size is 26.4×.
Price to free cash flow over time
Year by year
| Year | End of year | Low | High |
|---|---|---|---|
| 2026 so far | 16.6× | 11.9× | 28.9× |
| 2025 | 28.1× | 24.0× | 159× |
| 2024 | 148× | 135× | 154× |
| 2023 | 458× | 233× | 458× |
Against its peers
Companies in Medical - Instruments & Supplies nearest Inspire Medical Systems' size, closest first, today.
| Company | Price to free cash flow |
|---|---|
| INSPInspire Medical Systems | 16.6× |
| LMATLemaitre Vascular | 25.2× |
| UFPTUFP Technologies | n/m |
| EYENational Vision | 27.6× |
| CDRECadre | 17.3× |
| WRBYWarby Parker | 136× |
| STAAStaar Surgical | n/m |
| ATRCAtriCure | 57.3× |
| BVSBioventus | 11.7× |
| IARTIntegra Lifesciences | 12.3× |
| IRMDIradimed | 38.9× |
| Peer median | 26.4× |
What the price to free cash flow tells you
Market value divided by free cash flow: the cash left after running the business and paying for equipment. Cash is harder to manage than accounting earnings, so many investors trust this more than PE.
Lumpy: a big year of building factories drops cash flow and inflates the ratio without the business getting worse.
More on Inspire Medical Systems
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.